BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16258756)

  • 1. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
    Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
    Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
    Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
    Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
    Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma.
    Yu J; Habuchi T; Tsuchiya N; Nakamura E; Kakinuma H; Horikawa Y; Inoue T; Ogawa O; Kato T
    J Urol; 2004 Dec; 172(6 Pt 1):2410-3. PubMed ID: 15538282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
    Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
    Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
    Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
    Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
    Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
    Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Cylin D1 G870A polymorphism with laryngeal cancer: are they really related?
    Verim A; Ozkan N; Turan S; Korkmaz G; Cacina C; Yaylim I; Isbir T
    Asian Pac J Cancer Prev; 2013; 14(12):7629-34. PubMed ID: 24460344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
    McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
    Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.